
05/06/2025
Zepbound: A New Era in Obstructive Sleep Apnea Management
For the longest time, patients have if there is a drug (pill or injection) for treatment of Obstructive Sleep Apnea (OSA).
Now, there is!!!
Zepbound (Tirzepatide) is a once-weekly injectable medication which has been recently approved by FDA for treatment of moderate to severe OSA in patients who are overweight or obese.
This medication has traditionally been used for chronic weight management in individuals with obesity or those who are overweight and have weight-related health conditions, such as type 2 diabetes, high blood pressure, or sleep apnea.
By targeting two key hormones, GIP and GLP-1, Zepbound helps regulate insulin secretion and suppress appetite, leading to significant weight loss.
While effective, it's important to consult with a healthcare provider to understand potential risks, including gastrointestinal side effects and concerns about thyroid cancer, as well as to determine if Zepbound is suitable for your specific health needs.
Disclaimer: This is an educational post and not medical advice. If you or your loved ones suffer from sleep issues, call Telemedora at 650-687-7368 or visit telemedora.com to find out how we can help or talk to your doctor. At Telemedora, we focus on bringing quality sleep care to you in the comfort of your homes in a timely manner.
Follow us on social media.
Facebook: https://www.facebook.com/Telemedora/